Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Schnedl, C; Fahrleitner-Pammer, A; Pietschmann, P; Amrein, K.
FGF23 in Acute and Chronic Illness.
Dis Markers. 2015; 2015(12):358086-358086 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG


Autor/innen der Med Uni Graz:
Amrein Karin
Fahrleitner-Pammer Astrid
Schnedl Christian

Dimensions Citations:

Plum Analytics:
Number of Figures: 3
| | |
FGF23 is a bone-derived phosphaturic hormone that may become a useful biomarker for the identification of high-risk patients in chronic but also acute disease. It rises early in chronic kidney disease and is strongly and independently associated with excess morbidity and mortality. Emerging data suggest that FGF23 is also elevated in different scenarios of acute illness. In this review, we give an overview on the role of this interesting disease marker and potential and proven interventional strategies and discuss a blueprint for future research.
Find related publications in this database (using NLM MeSH Indexing)
Animals -
Biomarkers - blood
Biomarkers - metabolism
Cardiovascular Diseases - blood
Fibroblast Growth Factors - blood
Fibroblast Growth Factors - metabolism
Humans -
Renal Insufficiency, Chronic - blood
Sepsis - blood

© Meduni Graz Impressum